Form D — Nok Therapeutics, Inc.
0001213900-25-102036 · filed 2025-10-24
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $750,000
- Total sold
- $566,500
- Minimum investment
- $500
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Nok Therapeutics, Inc.
- CIK
- 2038166
- Entity
- Corporation
- Jurisdiction
- FLORIDA
- Year incorporated
- 2024
- Address
- 2009 MACKENZIE WAY
CRANBERRY TWP., PA 16066 - Phone
- 888-691-5839
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Robert Lewis · Executive OfficerMadison, MS Find on LinkedIn ↗
-
Brian Cogley · Executive OfficerCranberry Twp, PA Find on LinkedIn ↗
-
Bruce Cassidy · DirectorSarasota, FL Find on LinkedIn ↗
-
Martin Lewis · DirectorPlainview, TX Find on LinkedIn ↗
-
Michael Lewis · PromoterFort Myers, FL Find on LinkedIn ↗
-
David Mehalick · PromoterNaples, FL Find on LinkedIn ↗
View original on SEC EDGAR.